China Botanic Pharmaceutical Inc news

   Watch this stock
Showing stories 1 - 10 of about 12   

Articles published

CBP 0.550 0.000 (0.00%)
price chart
China Botanic Pharmaceutical Inc. Announces Receipt of Delisting Notice
HARBIN, China, May 7, 2013 /PRNewswire/ -- China Botanic Pharmaceutical Inc. (AMEX: CBP) (formerly Renhuang Pharmaceuticals, Inc.) ("China Botanic" or the "Company"), a developer, manufacturer and distributor of botanical products, ...
Related articles »  
Chi-Med License Agreement for Cancer Drug Probable by Year-End
... subsequent agreements giving Chi-Med the rights to China, Hogg said. China's pharmaceutical market is expected to grow as much as 18 percent a year to $165 billion by 2016, making it the world's second-largest market after the U.S.
Thorne Research and YouCare Pharmaceutical Group Announce Joint Venture ...
SANDPOINT, Idaho, April 30, 2013 /PRNewswire/ -- Thorne Research, Inc., a leader in developing and manufacturing pure, high-quality nutritional supplements and personal care products, today announced that the company has entered a joint venture with ...
Related articles »  
China Botanic Pharmaceutical Inc Reaffirms FY 2012 Guidance
China Botanic Pharmaceutical Inc Reaffirms FY 2012 Guidance
China Botanic Pharmaceutical Inc Reaffirms FY 2012 Guidance
China Botanic Pharmaceutical Inc Issues FY 2012 Guidance
China Botanic Pharmaceutical Inc Reaffirms FY 2011 Guidance